| Dialysis |
| 0.05 mol/L Tris, pH 8.0, 3.0 mol/L urea, 1.0 mmol/L EDTA, 2.5 mmol/L GSH and 0.8 mmol/L GSSG |
| 8.0 mol/L urea solution containing 0.05 mol/L Tris (pH 8.0), 1 mmol/L EDTA and 0.1 mol/L β-mercaptoethanol |
| 0.05 mol/L Tris, pH 8.0, 1.0 M NaCl, 3.0 mol/L urea, 1.0 mmol/L EDTA, 2.5 mmol/L GSH and 0.8 mmol/L GSSG |
| None |
| no tag |
| 8.0 |
| 25.0 |
| 2.8 mg/ml |
| n/a |
| GSH/GSSG |
| 2.5/0.8 mM,2.5/0.8 mM,2.5/0.8 mM,2.5/0.8 mM,2.5/0.8 mM |
| refolding of rhG-CSF by dilution. To run a blank gradient elution without injection sample under the same chromatographic conditions as those demonstrated above and collect the effluent corresponding to that of the whole rhG-CSF peak, the sample solution (400 uL) containing the denatured/ reduced rhG-csf in 8 mol/L urea was diluted with the collected effluent and then the solution was left for 24 h at 4 degree.
Procedures for the refolding and purification of rhG-CSF by IEC. Chromatographic runs were carried out at room temperature using a IEC column (20 × 1.2 cm i.d.) packed with Q Sepharose FF media with a bed volume of about 20 mL and connected to an ÄKTA Explorer 100A chromatographic system. The column was equilibrated with solution A consisting of 0.05 mol/L Tris, pH 8.0, 3.0 mol/L urea,1.0 mmol/L EDTA, 2.5 mmol/L GSH and 0.8 mmol/L GSSG. The sample solution (400 μL) containing the solubilized and denatured rhG-CSF with 2.8 mg/mL total protein (containing 1.15 mg/mL of rhG-CSF) in 8.0 mol/L urea solution was directly injected into the column. After washing the column with 30 mL of solution A, the refolding with simultaneous purification of rhG-CSF was accomplished after a linear gradient elution from 100% A to 60% B (solution B consistedof solution A plus 1.0 mol/L NaCl) in 90 mL at a flow
rate of 5.0 mL/min with detection at 280 nm. The column was
regenerated using 20 mL of 100% B. |
| SDS-PAGE |
| None |
| None |
| n/a |
| n/a |
| n/a |
| NOTE - protein was refolded into a buffer gradient from 0 to 60% buffer B. See above protocol. |